Introduction {#Sec1}
============

The interphase nucleus of a eukaryotic cell is highly compartmentalised. It contains subnuclear domains such as the nucleolus, splicing speckles, paraspeckles, Cajal and PML bodies, with the nucleolus being the most prominent subnuclear compartment (Handwerger and Gall [@CR35]; Austin and Bellini [@CR8]; Boisvert et al. [@CR12]). The nucleolus has a primary role in ribosome subunit biogenesis, with additional functions including acting as a stress sensor and in cell cycle control, leading to the view of the nucleolus as being multifunctional (Boisvert et al. [@CR12]; Boulon et al. [@CR15]; Pederson [@CR73]; Pederson and Tsai [@CR74]). Like other nuclear domains, the nucleolus is a dynamic compartment, and both its protein composition and general architecture change in response to environmental conditions (Andersen et al. [@CR7]; Boisvert et al. [@CR13]; Shav-Tal et al. [@CR88]). In addition, many nucleolar proteins are not exclusive to the nucleolus and also localise to other subcellular domains.

The nucleolus forms around arrays of ribosomal DNA (rDNA) on the five acrocentric chromosomes (chromosomes 13, 14, 15, 21 and 22 in human), the so-called nucleolar organizer regions (NORs). Human NORs consist of clusters of ∼400 individual rDNA repeats in total (per diploid genome); however, only a subset of these is transcribed. Active rDNA is distinguishable from inactive rDNA by specific epigenetic marks (i.e. DNA methylation and histone modification status) as well as by associated proteins. Inactive rDNA carries heterochromatic features, such as hypermethylated CpG islands at the rDNA promoter or hypermethylated histones like H3K9, with the latter leading to the association of heterochromatin protein 1 (HP1; reviewed in Huang et al. ([@CR37]) and McStay and Grummt ([@CR63])). Active rDNA, in contrast, is enriched in acetylated histones H3 and H4, and its promoter is hypomethylated. Additionally, factors of the RNA polymerase I (RNA pol I) machinery, including the upstream binding factor (UBF), are associated with the entire rDNA repeat and keep it in an undercondensed state (reviewed in Sanij and Hannan ([@CR83])). In the current model, regulation of rRNA transcription occurs by either changing the transcription rate of already active rDNA repeats and/or the number of transcriptionally active repeats. This can vary depending on the cell type, or during differentiation and development (Haaf et al. [@CR34]). The mammalian nucleolar remodelling complex is responsible for the coordination of factors regulating heterochromatin formation on rDNA (Santoro and Grummt [@CR84]; Santoro et al. [@CR85]; Strohner et al. [@CR94]; Zhou et al. [@CR112]). Interestingly, maintenance of heterochromatic rDNA by DNA repair mechanisms has recently also been linked to nucleolar and rDNA repeat integrity and may even influence heterochromatin formation elsewhere in the nucleus (Paredes and Maggert [@CR72]; Peng and Karpen [@CR75]), suggesting more extensive roles for nucleolar chromatin organisation.

In higher eukaryotes, the tripartite nucleolar architecture reflects the three main steps in ribosome subunit biogenesis, i.e. rDNA transcription, rRNA processing and ribosome subunit assembly. The fibrillar centre (FC) is enriched in components of the RNA pol I machinery. Transcription of rRNA is believed to take place either in the FC or at the border between the FC and the surrounding dense fibrillar component (DFC). The DFC is enriched in rRNA-processing factors, including snoRNAs and the snoRNP proteins such as fibrillarin and Nop58. Both the FC and DFC are embedded in the granular compartment (GC), where pre-ribosome subunits are assembled (reviewed in Boisvert et al. ([@CR12]) and Sirri et al. ([@CR90])). However, a number of publications have described factors localising to nucleolar regions different from FC, DFC or GC, probably revealing the existence of additional subnucleolar regions. First, coilin, Sm proteins and splicing snRNPs were detected within the nucleolus of specialized cell types in hibernating dormice, and in human breast cancer or HeLa cell lines upon phosphatase inhibition (Lyon et al. [@CR53]; Malatesta et al. [@CR58]; Ochs et al. [@CR70]). More recently, SUMO1 and the nuclear transport factor CRM1 were found in discrete intranucleolar foci (Desterro et al. [@CR22]; Ernoult-Lange et al. [@CR24]). However, the mechanisms causing this intranucleolar localisation have so far not been characterized in detail.

In this study, we identify proteins associated with RNA metabolism, protein turnover and DNA maintenance that localise to a distinct subnucleolar region separate from the FC, DFC and GC. We show the same intranucleolar structure, termed intranucleolar body (INB), can also be found in animal tissue and demonstrate it is promoted by specific DNA-damaging conditions without disrupting the structural and functional integrity of the nucleolus.

Materials and methods {#Sec2}
=====================

Cell culture and transfections {#Sec3}
------------------------------

HeLa, HEK293, C33A, HaCaT, HCT116, HepG2, HT1080, MCF7, U138 and U2OS cells were grown in DMEM (Invitrogen) containing 4.5 g/l glucose, 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. Tera-1 cells were grown in McCoy\'s 5a medium (Invitrogen) containing 20% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. CHO cells were grown in MEM α medium (Invitrogen) in the presence of 10% FCS, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. The stable HeLa cell line for EYFP-SUMO1 was generated and maintained by standard protocols using 400 μg/ml G418 as selective marker (Trinkle-Mulcahy et al. [@CR99]). HeLa cells stably expressing His-SUMO1 were a gift from Ron Hay (University of Dundee) and were maintained using 1 μg/ml puromycin. Transient transfections were performed with Effectene (Qiagen) according to the instructions of the manufacturer.

Bovine lens and human skin processing {#Sec4}
-------------------------------------

Bovine eyes were obtained fresh from the abbatoir and the lens dissected from the posterior aspect of the eye. Human skin samples were collected from patients undergoing surgery to revise scars at Ninewells Hospital, Dundee. Full ethical permission was obtained for the use of these tissue samples for research purposes. The skin samples were trimmed to a suitable size for sectioning; excess fat was removed. The tissues were frozen in iso-pentane cooled in liquid nitrogen and stored at −80°C prior to sectioning. Samples were sectioned at 20 μm on a Leica CM3050S cryostat.

Stress and drug treatment {#Sec5}
-------------------------

To introduce DNA double strand breaks (DSBs) by gamma irradiation (IR), cells were exposed to 10 Gy using a ^137^Cs source and left to recover for the times indicated. Alternatively, cells were incubated for 24 h in the presence of either 2 mM hydroxyurea (HU; Sigma), 25 nM camptothecin (CPT; gift from John Rouse (University of Dundee)) or for 3 h in the presence of 50 μM etoposide (eto; Sigma). UV-C irradiation was performed as described in Cioce et al. ([@CR20]) and cells left to recover for 3 h. 4-Nitroquinoline 1-oxide (NQO, Sigma) was used as UV-mimetic agent at 1 μM for 3 h. To specifically inhibit RNA polymerase I transcription, cells were incubated in the presence of 5 nM actinomycin D (actD; Sigma) for times as indicated.

Plasmids {#Sec6}
--------

The cDNA for PA28γ and PPM1G was inserted into pEGFP-C1 (clontech) via BamHI and HindIII or BglII and KpnI, respectively. pcDNA-mCherry was generated by insertion of mCherry via Asp718 and BamHI into pcDNA4 (Invitrogen; gift from Archa Fox (Western Australia Institute for Medical Research)). The cDNA for fibrillarin was inserted into pcDNA4-mCherry via BamH1 and EcoRI. The cDNA for SENP3 and SENP5 was cloned into pmCherry-C1 XhoI and SalI or HindIII and SalI, respectively. pDendra2-C1 was generated by replacing the ORF for GFP by Dendra2 in the pEGFP-C1 backbone using PCR without affecting the MCS, and the cDNA for SUMO1 inserted via BglII and SalI to obtain Dendra2-SUMO1. The 11.9-kbp EcoRI rDNA probe was a gift from Brian McStay (NUI Galway, Ireland). GFP-SUMO1 and GFP-SUMO2/3 were gifts from Ron Hay (University of Dundee).

Antibodies {#Sec7}
----------

Antibodies were used as follows for immunofluorescence studies: mouse anti-RPA194 (Santa Cruz; 1:50), anti-fibrillarin (monolayers: abcam; 1:300; lens tissue sections: 72B9, Cytoskeleton Inc., 1:10), anti-B23 (Sigma; 1:500), anti-CDC5L (BD; 1:200), anti-TRIM28 (BD; 1:300), anti-DPK (Calbiochem; 1:100), anti-Ku70 (abcam; 1:100), anti-PA28γ (BD; 1:100), anti-TMG (Oncogene; 1:10), anti-coilin (5P10; 1:10 (Rebelo et al. [@CR81])), anti-HP1α (euromedex; 1:500) and anti-CPD (CosmoBio Co, LTD.; 1:1,000); anti-RNA polymerase II CTD repeat (4H8, abcam; 1:300); rabbit anti-PPM1G (Bethyl laboratories; 1:300), (mouse) anti-RNA polymerase II CTD repeat (4H8, abcam; 1:300) anti-nucleolin (abcam; 1:1,000), anti-PA28γ (MBP; 1:300), anti-UBF (HPA/Sigma; 1:100), anti-H3K9me3 (abcam; 1:100), anti-H4K16ac (milipore upstate; 1:100), anti-H4K20me3 (abcam; 1:400), anti-phosphoSer139 H2AX (upstate; 1:200) and anti-PCNA (abcam; 1:300); goat anti-Nop58 (Santa Cruz; 1:100); and sheep anti-SUMO1 and SUMO2/3 (gift from Ron Hay (University of Dundee); 1:300 or 1:100 for monolayers respectively, 1:20 for EM and tissue sections). For western blot, the rabbit anti-phosphoSer139 H2AX antibody was used 1:500 in 3% milk in TBS/0.1% Tween.

Immunofluorescence and fluorescence microscopy {#Sec8}
----------------------------------------------

For immunofluorescence staining of cell monolayers, HeLa cells were grown on poly-[l]{.smallcaps}-lysine-coated coverslips, fixed in 3.7% paraformaldehyde/PHEM buffer (120 mM PIPES, 55 mM HEPES, 20 mM EGTA, 8 mM MgSO4, pH 7) for 7 min and permeabilized in 1% TX-100/PBS for 15 min at room temperature (RT). Cells were blocked for 10--15 min in blocking buffer (0.2% fish gelatine \[Sigma\] in PBS) and incubated with primary antibodies in blocking buffer for 1--2 h at RT. Secondary antibodies were from Molecular Probes (donkey anti-mouse or rabbit Alexa 488, Alexa 594 or Alexa 647, anti-goat Alexa 488 or anti-sheep Alexa 488 or Alexa 546). Washing steps were performed with PBS/0.1% Tween-20. DNA was stained with Hoechst at 12.5 μg/ml in PBS and cells mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA). Images were acquired with a DeltaVision Core Restoration microscope mounted on an Olympus IX71 stand with a ×60 1.42 NA oil immersion objective lens using either 1 × 1 or 2 × 2 bin with a section spacing of 0.2 μm. Exposure time was set to provide an intensity of ∼1,000 counts on a 12-bit Coolsnap HQ camera (Roper, USA). Processing and analysis was performed using SoftWorx (Applied Precision) and Adobe Photoshop. To determine the diameter of the INB in HeLa and U2OS cells, the area of the INB was measured at its largest dimension in *z* in 10--20 cells using the polygon function in SoftWorx. The diameter was then calculated under the premise of a circular shape of the INB from the obtained values.

For immunofluorescence of lens and skin tissue sections, frozen sections were fixed in 4% paraformaldehyde in PBS, permeabilised with 1% Nonidet P40 in PBS, blocked with normal donkey serum (10%), stained with sheep anti-SUMO2 and mouse anti-fibrillarin and counterstained with donkey anti-sheep IgG Alexa 488, donkey anti-mouse IgG Alexa 594 and DAPI. Sections were imaged on an LSM700 laser scanning confocal microscope (Carl Zeiss) using a ×100 alpha Plan-Apochromat objective (NA 1.46).

Time-lapse imaging, FRAP and photoconversion {#Sec9}
--------------------------------------------

All live cell experiments were performed ∼18--24 h after transient transfection using a DeltaVision Spectris wide field deconvolution microscope/Olympus IX71 stand in a 37°C chamber with CO~2~-independent medium. For time-lapse microscopy and fluorescence recovery after photobleaching (FRAP) analysis, images were acquired using an Olympus ×60 1.40 NA oil immersion objective lens and either 2 × 2 bin or 4 × 4 bin, respectively. FRAP and Photoconversion experiments were done using a DeltaVision Core Restoration Microscope equipped with a Quantifiable Laser Module (Applied Precision). For FRAP, imaging and bleaching conditions were chosen to match proteins with the highest turnover by using a 4 × 4 bin. A 488-nm diode laser was used to bleach to approximately 50% of initial intensity. For photoconversion, intranucleolar Dendra2-SUMO1 was photoconverted using the 405-nm laser at low intensity (10%) to avoid photodamage. Images were acquired using an Olympus ×100/1.35 NA lens and 4 × 4 bin using low exposure times in order to avoid further photoconversion due to light exposure during image acquisition.

Preparation of nucleoli {#Sec10}
-----------------------

Nucleoli were isolated from HeLa cells (ten 14-cm dishes) as previously described (Andersen et al. [@CR7]) except that a 0.35 M sucrose buffer supplemented with 2.5 mM MgCl~2~ was used. The final nucleolar pellet was resuspended in 0.35 M sucrose/0.5 mM MgCl~2~, frozen in liquid N~2~ and stored at −80°C.

Electron microscopy {#Sec11}
-------------------

Isolated nucleoli and whole cells were fixed in 4% paraformaldehyde in 0.2 M PIPES, washed, cryoprotected in 2.3 M sucrose and frozen in liquid nitrogen. Semi-thin sections (200 nm for scanning electron microscopy (SEM)) and ultra-thin sections (70 nm for transmission electron microscopy (TEM)) were cut on a Leica Ultracut EM-FCS cryo-ultramicrotome. Semi-thin sections were collected on polished silicon wafer (Agar), post-fixed with 1% gluteraldehyde and 1% OsO~4~ in PBS, critical point dried and sputter coated with gold/palladium. The semi-thin sections were imaged at high vacuum on an XL-30 ESEM (FEI). Ultra-thin sections were collected on Formvar/carbon-coated grids and immunolabelled with SUMO1 antibody followed by rabbit anti-sheep IgG and Protein A colloidal gold (BBI). The immunogold-labelled sections were imaged on a Tecnai 12 TEM (FEI).

DNA FISH {#Sec12}
--------

For combined immunofluorescence and rDNA FISH, cells were grown on microscope slides, and the immunofluorescence was performed as described above except that the primary and secondary antibody were used two to five times as concentrated, respectively. After washing of the secondary antibody, cells were fixed again for 10 min in 3.7% PFA/PHEM and gradually warmed up to 75°C in a water bath for 45 min in 2× SSC. Cells were incubated 10 min each in 70% ethanol and absolute ethanol, and DNA was subsequently denatured by 10 min incubation in 0.1 M NaOH. Cells were incubated 7 min in 2× SSC and finally dehydrated by 10 min incubation in 70% ethanol followed by 10 min in absolute ethanol. Slides were air-dried and pre-warmed for 5 min at 37°C before the hybridization.

**FISH-probe** Five microgrammes of plasmid coding for the 11.9-kb EcoRI restriction fragment corresponding to the human intergenic spacer sequence (IGS) upstream of the gene promoter for rDNA (Mais et al. [@CR57]) was nick-labelled with 1 mM Cy3-dCTP or Cy5-dCTP using a nick-translation kit (GE Healthcare Life Sciences) according to the manufacturer\'s instructions. One microgramme of labelled probe was precipitated in ethanol and 0.3 M sodium acetate together with 10 μg COT1 carrier DNA (Invitrogen) and dissolved in 12 μl hybridization buffer (Hybrisol, Abbot Molecular, Maidenhead, UK). A directly labelled fluorescent telomeric probe for the short arm of chromosome 4 (4p) was obtained from Cytocell (Cambridge, UK). Probes were pre-warmed at 37°C for 5 min.

**Hybridization and washing** Probes were added to pre-warmed slides, and slides were sealed with a coverslip and rubber cement, subsequently denatured for 2 min at 75°C and hybridized in a wet chamber overnight at 37°C. After removing the coverslips, slides were washed in 2× SSC at 75°C for 2 min, 1 min in 0.4 SSC/0.05% TX-100 at RT and rinsed briefly in PBS. DNA was counterstained with Hoechst as described above.

Metabolic labelling of rRNA with 5-ethynyl uridine (EU) or \[5,6-^3^H\]uridine {#Sec13}
------------------------------------------------------------------------------

Labelling of RNA by 5-ethynyl uridine (EU) for microscopy was performed using the Click-IT RNA Imaging kit (Invitrogen) according to the manufacturer\'s instructions. Labelling of newly synthesized rRNA with \[5,6-^3^H\]-uridine was performed according to Pestov et al. ([@CR76]). Total RNA was isolated (Qiagen RNA kit), and equal amounts of total RNA were loaded onto an agarose gel, electroblotted onto a nylon membrane and analysed by autoradiography.

Counterflow centrifugal elutriation (CCE) and cell cycle analysis by flow cytometry {#Sec14}
-----------------------------------------------------------------------------------

To enrich for cells in G1 phase, counterflow centrifugal elutriation (CCE) was performed with ∼1.5--2.0 × 10^8^ of exponentially growing HeLa cells according to Kaufman et al. ([@CR39]) using a Beckman J6-MI centrifuge and a JE-6B elutriation rotor at 3,000 rpm at room temperature. The G1-fraction was washed once in DMEM and cells re-seeded for cell cycle progression into dishes with coverslips.

For analysis of the cell cycle stage, cells were trypsinized at different time points after re-seeding (2, 12 and 18 h), washed in PBS/1% BSA and fixed in ice-cold 70% ethanol for at least 30 min at room temperature or overnight. DNA was stained using 50 μg/ml propidium iodide in the presence of 50 μg/ml RNase-A and 0.1% TX-100. Data were acquired using a FACS Calibur cytometer (Becton Dickinson, USA) and CellQuest software. Cells were gated by their forward and side scatter profiles, and cell cycle analysis was performed using the Watson (pragmatic) model in the FloJo software (Treestar, USA).

Results {#Sec15}
=======

The intranucleolar body is a distinct nucleolar compartment {#Sec16}
-----------------------------------------------------------

We and others have observed protein components including coilin, the splicing factor CDC5L and the post-translational peptide modifier SUMO1 in a discrete region within the nucleolus (Ajuh et al. [@CR3]; Desterro et al. [@CR22]; Lyon et al. [@CR53]; Malatesta et al. [@CR58]; Ochs et al. [@CR70]; Sleeman et al. [@CR93]; Sleeman and Lamond [@CR92]). Here, we show that PA28γ/PSME3, the nuclear isoform of the 11S proteasome activator complex, displays a similar localisation in the nucleolus. PA28γ has been shown to interact with the 20S proteasome in an ubiquitin-independent degradation pathway for cellular proteins including p21, p16 and p19 (Chen et al. [@CR18]). Previously, we have demonstrated that PA28γ is a mediator in the response of Cajal bodies to UV-C stress (Cioce et al. [@CR20]). The intranucleolar location for PA28γ does not overlap with any of the markers for the three main nucleolar compartments, as shown by co-immunofluorescence with either the RNA polymerase I subunit RPA194 as a marker for the FC, fibrillarin for the DFC or B23 for the GC (Fig. [1a](#Fig1){ref-type="fig"}, arrows). PA28γ forms a discrete spot in the same region within the nucleolus as both coilin and CDC5L (arrows in Fig. [1](#Fig1){ref-type="fig"}b and data not shown), suggesting they localize to the same subnucleolar structure. In accordance with earlier publications, we also found SUMO1 to form distinct intranucleolar spots in HeLa cells stably expressing YFP-SUMO1, similar to the localisation of PA28γ (Desterro et al. [@CR22] and Fig. [1b](#Fig1){ref-type="fig"}, arrows). We also found endogenous SUMO1 forming intranucleolar bodies (INBs), however with reduced size and abundance as compared with cells stably expressing YFP-SUMO1 or His-SUMO1 (data not shown). We conclude the INB localisation is not only caused by overexpression of SUMO1. The SUMO localisation likely corresponds to SUMO1 conjugated to substrate proteins because a non-conjugatable SUMO1 mutant missing the last two amino acids (SUMO1ΔGG) does not form an INB (Desterro et al. [@CR22]; data not shown). Also, overexpression of the nucleolar forms of SUMO-specific proteases SENP3 or SENP5, but not of the nucleolar marker fibrillarin, led to a loss of the INB staining for YFP-SUMO1 (Fig. [1c](#Fig1){ref-type="fig"}). Fig. 1The intranucleolar body is a sub-nucleolar compartment distinct from known nucleolar regions. **a** HeLa cells were stained by specific antibodies for PA28γ and either the RPA194 subunit of the RNA pol I complex (pol I), fibrillarin (fib) or B23 as marker proteins for the FC, DFC or GC, respectively. The INB is indicated by *arrows*. *Bar*, 10 μm. **b** HeLa cells were double labelled with specific antibodies for endogenous PA28γ and either coilin, the 5′-terminal trimethylguanosine cap structure (TMG) or the C-terminal domain of RNA pol II (pol II). In the *third row*, HeLa cells stably expressing EYFP-SUMO1 were used to stain for endogenous PA28γ. The INB is indicated by *arrows*. *Bar*, 10 μm. Note that no DNA stain is shown in the *insets*. **c** HeLa cells stably expressing EYFP-SUMO1 were transiently transfected with constructs coding for either mCherry-fibrillarin (fib), -SENP3 or -SENP5 and analysed for the presence of the intranucleolar SUMO1-body (*arrowheads*) by fluorescence microscopy. Note that for reasons of visibility, different exposure times were used for YFP-SUMO1. *Bar*, 10 μm. **d** Bovine lens tissue sections were processed and stained with specific antibodies to SUMO2 (*green*) and fibrillarin (*red*) and subsequently analysed by confocal microscopy. A cross section through the whole lens is shown in (*I*) with the epithelial layer indicated by a *box*. *Bar*, 50 μm. A midplane of epithelial cells in all three planes is shown in (*II*). The INB is indicated by an *arrow*. *Bar*, 5 μm. Magnifications of a nucleolus with SUMO2-intranucleolar body in all three midplanes are enlarged in the *panel below*. For clarity, only the stain for SUMO2 (*green*) and fibrillarin (*red*) is shown here

In addition to PA28γ and SUMO1, we have identified 19 protein factors that localise to the same INB structures using validated antibodies against commonly used nuclear markers (as shown in Table [1](#Tab1){ref-type="table"}). This includes proteins involved in DNA repair and replication, protein turnover, RNA processing and chromatin organisation as well as SUMO2/3. An antibody against the 5′-terminal trimethylguanosine cap structure (TMG) also labels the same INB, suggesting the presence of small RNAs such as snRNA or snoRNAs (Fig. [1b](#Fig1){ref-type="fig"}). This is in agreement with earlier findings that reported the presence of several U snRNPs within the mammalian nucleolus (Ganot et al. [@CR27]; Gerbi and Lange [@CR29]; Lyon et al. [@CR53]; Sleeman et al. [@CR93]; Sleeman and Lamond [@CR92]; Tycowski et al. [@CR101]) as well as the presence of TMG-labelling in the yeast nucleolus (Potashkin et al. [@CR78]). Table 1Components identified within the intranucleolar body (INB)Protein namesUniprotEndogenousFP-taggedProtein functionReferencesPCNAP12004++DNA replication/repairMoldovan et al. [@CR65]; Stucki et al. [@CR95]Mcm3P25205+n.a.DNA replicationMaiorano et al. [@CR56]Mcm7P33993+n.a.DNA replicationKu70P12956+n.a.DNA repairMahaney et al. [@CR55]; Weterings and Chen [@CR107]DNA-PKcsP78527+n.a.DNA repairCdc5LQ99459++Pre-mRNA splicing, cell cycle controlAjuh et al. [@CR2], [@CR3]; Boudrez et al. [@CR14]PLRG1O43660+n.a.Pre-mRNA splicingAjuh et al. [@CR2], [@CR3]; Rappsilber et al. [@CR80]Prp19Q9UMS4+n.a.DNA repair, pre-mRNA splicing, E3 ligase activity, interactor with 20S proteasomeGrillari et al. [@CR32]; Loscher et al. [@CR50]; Mahajan and Mitchell [@CR54]; Zhang et al. [@CR110]SF2/ASFQ07955+n.a.Pre-mRNA splicingZuo and Manley [@CR113]U2AF65P26368+n.a.Pre-mRNA splicingRappsilber et al. [@CR80]U1/U2 snRNP--n.a.Pre-mRNA splicingLyon et al. [@CR53]Sm proteins (Y12 antibody)--++ (SmB)Pre-mRNA splicingSleeman and Lamond [@CR92]PPM1G/PP2CγQ6IAU5++Ser/Thr phosphatase, histone exchange factor, pre-mRNA splicingKimura et al. [@CR40]; Murray et al. [@CR66]; Petri et al. [@CR77]; Travis and Welsh [@CR98]PNUTS/p99Q96QC0++Inhibitor of protein phosphatase 1, DNA damage responseKreivi et al. [@CR42]; Landsverk et al. [@CR45]CRM1O14980++Protein transport, intranuclear transport of snRNPsHutten and Kehlenbach [@CR38]; Sleeman [@CR91]PA28γ/PSME3P61289++Proteasome activator, UV-stress response of CBs, controls PML body number, chromosomal stabilityChen et al. [@CR18]; Cioce et al. [@CR20]; Zannini et al. [@CR109], [@CR108]20S proteasome--+n.a.Protein turnoverGallastegui and Groll [@CR26]CoilinP38432++Component of Cajal bodiesGall [@CR25]; Ogg and Lamond [@CR71]SUMO1P63165++PTMGeiss-Friedlander and Melchior [@CR28]; Meulmeester and Melchior [@CR64]; Ulrich [@CR102]SUMO2/3P61956/P55854++PTMTRIM28/KAP-1Q13263+n.a.Transcriptional co-repressorUrrutia [@CR103]Trimethylguanosine cap (TMG)--+n.a.Andersen and Zieve [@CR6]"+" identified, *n.a.* not analysed

The INB appears totally enclosed within the nucleolus, as judged by fibrillarin or nucleolin co-staining, and therefore is not likely to be a nucleoplasmic invagination. Other nuclear proteins, such as RNA polymerase II, the SR protein SRp55 and topoisomerase II beta (Fig. [1](#Fig1){ref-type="fig"}b and data not shown), are not detected within the INB, suggesting only specific factors localise to this sub-region within the nucleolus. For some factors, we observe a partial overlap within the INB (e.g. coilin and PA28γ (Fig. [1b](#Fig1){ref-type="fig"})). The INB detected with YFP-SUMO1 appears surrounded by an outer shell of PA28γ (Fig. [1b](#Fig1){ref-type="fig"}). This suggests that these proteins each occupy a defined space or associate differentially with structures within the INB, rather than localise there by diffusion, as had been suggested for p53 (Kruger and Scheer [@CR43]).

The INB can be found in ∼30--40% of HeLa cells and also in other cells types, albeit with different frequencies (see Table [2](#Tab2){ref-type="table"}). The INB exists mostly as a single nucleolar body; however, multiple INBs per single nucleolus can occasionally be observed. The diameter of an INB can vary from ∼0.5 to 1.6 μm in HeLa and ∼0.4 to 1.0 μm in U2OS cells. Table 2Frequency of the intranucleolar body (INB) for PA28γ in different cell linesCell lineTissue of origin (species)Number of experimentsCells with INB \[%\]STD \[%\]293Kidney (human)36.3±1.7C33ACervix (human)316.0±5.8CHOOvary (hamster)316.9±4.0HaCaTSkin (human)314.0±2.8HCT116Colon (human)310.9±4.6HepG2Liver (human)320.1±3.9HT1080Connective tissue (human)310.4±1.9MCF7Breast (human)432.4±10.0Tera-1Testes (human)38.3±4.7U138Brain (human)29.1±5.2U2OSBone (human)310.2±2.8A minimum of 100 cells per experiment was evaluated for the presence of the INB by double labelling for PA28γ and nucleolin*STD* standard deviation

To investigate whether the INB results from cell transformation and/or culturing conditions, we analysed primary cells from animal tissue for the presence of the INB. The eye lens offers the opportunity to analyse cells of different developmental stages and with different levels of transcriptional activity in a single histological section (Dahm et al. [@CR21]; Gribbon et al. [@CR31]). Examining cross sections of bovine lens, we found that antibodies against SUMO2 stain a discrete spot within the nucleolus of the epithelial layer (Fig. [1d](#Fig1){ref-type="fig"}). This SUMO2 signal is completely surrounded by fibrillarin as shown by the projections in all three planes and therefore likely to correspond to the same INB observed before in cultured cell lines (arrow in Fig. [1](#Fig1){ref-type="fig"}d panel II and magnification thereof). This intranucleolar localisation can be spatially distinguished from nucleoplasmic foci, presumably PML bodies, found adjacent to the nucleolus. Using specific antibodies, no PML could be found within the INB (data not shown). No intranucleolar SUMO2 was found in differentiated fibre cells (data not shown), indicating that this reflects a cell feature characteristic of the epithelial layer. Additionally, we could detect an INB for SUMO1 in skin epithelial cells (Supplementary Figure S[1](#Fig7){ref-type="supplementary-material"}).We conclude that the presence of the INB in tissue suggests it may have a physiological role in primary cells. Therefore, we pursued further analysis using the cell culture system.

Highly purified preparations of nucleoli can be isolated from cultured cells. By using the YFP-SUMO1 stable cell line, we monitored each fractionation step for the presence of the SUMO1-INB by fluorescence microscopy (data not shown). When these purified nucleoli were analysed as 200 nm cryo-sections by SEM, we observed cavities of varying size (Fig. [2a](#Fig2){ref-type="fig"}). The same nucleoli were subjected to immunogold staining for SUMO1 and TEM as 70 nm cryo-sections. Gold particles were found enriched around the edges as well as within of nucleolar cavities (Fig. [2b, c](#Fig2){ref-type="fig"}, arrowheads). This suggests that the cavities may correspond to the INB observed by fluorescence microscopy in intact cells. Fig. 2The intranucleolar body by EM. Nucleoli purified from HeLa cells stably expressing EYFP-SUMO1 were analysed as 200-nm cryo-sections by scanning electron microscopy (**a**) and as 70-nm cryo-sections for immunoelectron microscopy in the transmission electron microscope using antibodies against SUMO1 and secondary antibodies conjugated to 10-nm immunogold (**b**, **c**). *Scale bars*, 1 μm in **a** and 100 nm in **b**, **c**. In **c**, a magnification of the intranucleolar immunogold labelling from the nucleolus in **b** is shown. Immunogold labelling for SUMO1 is indicated by *arrowheads*

The intranucleolar body is a dynamic compartment {#Sec17}
------------------------------------------------

The nucleolus is a dynamic organelle with many proteins either shuttling between the nucleolus and nucleoplasm (Tsai and McKay [@CR100]) or else trafficking through it as part of their maturation pathway (reviewed in Gerbi et al. ([@CR30])) or altering their association in response to metabolic conditions (Andersen et al. [@CR7]). To analyse whether INB components exchanged with surrounding nucleoplasmic protein populations, we analysed different GFP-fusion proteins by FRAP following transient transfection. Different INB components displayed different dynamic behaviour (Fig. [3a, b](#Fig3){ref-type="fig"}). For example, when either GFP-PA28γ or GFP-PPM1G was photobleached, the intranucleolar pool recovered within ∼1 min. The turnover of these proteins was so high that the recovery already started during the bleaching event. In contrast, intranucleolar GFP-SUMO1 or GFP-SUMO2/3 could be efficiently bleached and did not recover within the same time frame, indicating that compared with either PA28γ or PPM1G, a large portion of SUMO within the nucleolus exchanges only slowly (Fig. [3a, b](#Fig3){ref-type="fig"} for SUMO1 and data not shown). In contrast to this nucleolar population, GFP-tagged SUMO1 and SUMO2/3 in the nucleoplasm recovered within seconds after the bleach (data not shown). This is in agreement with earlier data, showing different dynamics of the SUMO paralogues in different subnuclear compartments (Ayaydin and Dasso [@CR9]). Similar results were obtained with HeLa cells stably expressing either YFP-SUMO1 or YFP-SUMO2/3 (data not shown). By time-lapse imaging, we observed intranucleolar SUMO1 recovered eventually within ∼30--60 min after the initial bleach, demonstrating that SUMO1 within the nucleolus is turned over slowly. Fig. 3Dynamics of the intranucleolar body. **a**, **b** FRAP analysis of HeLa cells transiently expressing either GFP-SUMO1, -PA28γ or PPM1G. The normalized, average recovery curves of the intranucleolar body with standard deviation of at least 20 individual cells are shown in **a**. A representative cell expressing either GFP-PA28γ (*top*) or GFPSUMO1 (*bottom*) is shown at the time directly before (pre-bleach), at the moment of bleach (bleach) and at two time points after the bleach (post-bleach; **b**). The bleached region is indicated (*circle*). *Bar*, 10 μm. **c** Time-lapse microscopy of the intranucleolar body for Dendra2-SUMO1 in HeLa cells before (before UV) and after photoconversion (0--4 h UV) with a 405-nm laser (UV). Non-photoconverted Dendra-Sumo2 (*green*, *top*) and photoconverted Dendra2-SUMO1 (*red*, *bottom*, indicated by *arrowhead*) are shown as merge with bright-field images acquired by Koehler illumination. Photoconverted Dendra-SUMO1 populations appearing in the nucleoplasm are indicated by *arrows*. *Bar*, 10 μm. **d** HeLa cells transiently expressing GFP-SUMO1 were analysed over time by time-lapse microscopy. A merge of the fluorescence image DIC is shown. Time in shown in hours:minutes. INBs are indicated (*arrows*). *Bar*, 10 μm

Fusions with photoconvertable fluorescent proteins (e.g. Dendra2) allow observation of a locally defined subpopulation of the protein of interest and the analysis of its dynamic behaviour over time (Chudakov et al. [@CR19]). Dendra2-SUMO1 localises like GFP-SUMO1 to the INB as well as nucleoplasmic PML bodies (Fig. [3c](#Fig3){ref-type="fig"}). Dendra2-SUMO1 within the INB was photoconverted into its red isoform (arrowhead in Fig. [3c](#Fig3){ref-type="fig"}) using a 405-nm laser and subsequently analysed by time-lapse microscopy. Approximately 2 h after photoconversion of the nucleolar SUMO1, red foci appeared in the nucleoplasm (arrows in Fig. [3c](#Fig3){ref-type="fig"}). They increased in size as well as in intensity over time while the red foci in the nucleolus decreased. Neighbouring cells expressing Dendra2-SUMO1 that had not been photoconverted by the laser did not exhibit any red foci at the end of the experiment, confirming these nucleoplasmic foci derived from the converted nucleolar protein pool. These results show that the nucleolar SUMO1 constantly exchanges with other nuclear compartments, but with a low rate.

Due to the different optical density of the surrounding nucleolar material, the INB can also be visualized by differential interference contrast microscopy (DIC), appearing as a distinct, round structure within the nucleolus. Fluorescence imaging of HeLa cells transiently expressing GFP-SUMO1 confirms the presence of GFP-SUMO1 within this INB detected by DIC (Fig. [3d](#Fig3){ref-type="fig"} (arrows) and Supplementary Movies [1](#MOESM5){ref-type="media"}, [2](#MOESM6){ref-type="media"}, [3](#MOESM7){ref-type="media"} and [4](#MOESM8){ref-type="media"}). Within the time frame of a few hours, the INB exhibited surprisingly dynamic macroscopic behaviour. It appeared to vary in size, either by fusion of several small structures into one larger INB or by shrinking. Occasionally, a short-term increase in the nucleoplasmic fluorescence for SUMO1 accompanied the disappearance of the INB, suggesting the release of its content into the nucleoplasm (see Movie [2](#MOESM6){ref-type="media"} in Supplementary Data). The INB did not appear to originate from nucleoplasmic invaginations, suggesting it forms within the nucleolus. These data indicate that the INB is not a rigid part of the nucleolar architecture, but rather appears and disappears periodically. We therefore sought to find conditions that either favour or inhibit its formation.

Induction of the intranucleolar body by specific DNA damaging agents {#Sec18}
--------------------------------------------------------------------

We next analysed the response of the INB to different stress treatments. IR is known to induce DNA DSBs, leading to the formation of phosphorylated H2AX-foci (γH2AX) at the site of DSBs (Fig. [4c](#Fig4){ref-type="fig"}, left panel). HeLa cells were exposed to an IR-dose of 10 Gy, left to recover for 3 h and subsequently analysed by indirect immunofluorescence for the presence of the INB. As exemplified for PA28γ (Fig. [4a, b](#Fig4){ref-type="fig"}) and His-SUMO1 (Supplementary Figure S[2](#Fig8){ref-type="supplementary-material"}a, b), the percentage of cells showing an INB was increased after IR treatment. Whereas ∼40% (PA28γ) and ∼30% (His-SUMO1) of cells displayed an INB under non-stressed conditions, this frequency increased to ∼75% upon IR for PA28γ and ∼60% for His-SUMO1. We also noticed an increase in the average size of the INB (data not shown). The maximum percentage of cells displaying an INB was reached at ∼3 h after irradiation and maintained up to ∼10 h until cells started to recover at 12--24 h (data not shown). Fig. 4The intranucleolar body is induced by specific types of DNA-damage. **a** Untreated HeLa cells (−IR) or cells 3 h after exposure to 10 Gy (+IR) were analysed by co-immunofluorescence for PA28γ and nucleolin. The INB is indicated by an *arrow*. *Bar*, 10 μm. **b** Quantification of HeLa cells displaying an intranucleolar body for endogenous PA28γ after various stress treatments. *Error bars* represent the standard deviation of *n* = 5 (IR, 3 h recovery), *n* = 3 (HU, eto, UV, NQO) and *n* = 4 (CPT) independent experiments with \>100 cells evaluated each. *p* values were determined using a heteroscedastic, two-tailed *t* test and are indicated as *single asterisk* for *p* ≤ 0.05 (significant) and *double asterisk* for *p* ≤ 0.01 (highly significant). **c** Immunofluorescence for γH2AX (*left panel*) of untreated (−), γ-irradiated (IR), camptothecin (CPT) or hydroxyurea (HU)-treated HeLa cells. The *right panel* shows an immunofluorescence for cyclobutane pyrimidine dimers (CPD) in either untreated HeLa cells (−) or cells exposed to UV-C (UV). **d** HeLa cells were treated with 25 nM CPT for 24 h and double labelled with antibodies for endogenous PA28γ and either Ku70 (*upper panel*) or DPK (*lower panel*). *Arrows* point to the localisation of the INB. *Bar*, 10 μm

To test whether the formation of an INB is promoted by a specific response to DSBs or by DNA damage in general, we tested whether other DNA-damaging agents had the same effect. Short-term treatment with the topoisomerase II inhibitor etoposide as well as prolonged incubation with either the topoisomerase I inhibitor camptothecin (CPT) or the replication fork stalling agent hydroxyurea (HU) have been described to result in DSBs upon DNA replication (Lundin et al. [@CR52]; Ryan et al. [@CR82]; Long et al. [@CR49]). These treatments also induce the phosphorylation of H2AX (Fig. [4c](#Fig4){ref-type="fig"}, left panel; Supplementary Figure S[2](#Fig8){ref-type="supplementary-material"}d). HeLa cells were incubated either for 3 h in the presence of 50 μM etoposide (eto) or for 24 h in the presence of either 25 nM CPT or 2 mM HU, and analysed by indirect immunofluorescence. All reagents caused a significant increase in the number of cells displaying an INB for either PA28γ or His-SUMO1 (Fig. [4](#Fig4){ref-type="fig"}b and Supplementary Figure S[2](#Fig8){ref-type="supplementary-material"}b). Similar results were obtained for other INB components, including CDC5L and PPM1G, suggesting this stress-induced increase reflects a common cellular response shared by other components of the INB (data not shown). In contrast to IR, CPT or HU treatment, UV-C treatment did not result in an increase, but rather in a reduction, of the number of cells exhibiting an INB (Fig. [4](#Fig4){ref-type="fig"}b and Supplementary Figure S[2](#Fig8){ref-type="supplementary-material"}b). UV-C irradiation does not result in DSB but in covalent adducts between adjacent pyrimidines on the DNA strands (cyclobutane pyrimidine dimers (CPDs); Tornaletti and Pfeifer [@CR97]; Fig. [4c](#Fig4){ref-type="fig"}, right panel). Similar results were obtained using the UV-mimetic 4-nitroquinoline 1-oxide (NQO; Fig. [4](#Fig4){ref-type="fig"}b and Supplementary Figure S[2](#Fig8){ref-type="supplementary-material"}b; Al-Baker et al. [@CR4]; Tanooka and Tada [@CR96]). This might indicate that the formation of the INB is triggered only by distinct types of DNA damage, such as DSBs and/or stalled replication forks, and therefore reflects a specific stress response by the cell.

Alternatively, the formation of the INB might be a consequence of a cell cycle arrest caused by the different DNA-damaging agents. Therefore, we analysed the cell cycle distribution of HeLa cells treated with either IR, eto, CPT or HU. The different stress treatments resulted in different cell cycle distributions (Supplementary Figure S[3](#Fig9){ref-type="supplementary-material"}a--d). Whereas IR and etoposide treatment seemed to arrest cells in S and G2 phase, CPT and HU treatment arrested cells in G2 or late G1/early S phase, respectively. As about a third of unstressed HeLa cells display an INB, we set out to analyse the frequency of the INB during an unperturbed cell cycle. To avoid involvement of any drugs that might influence the abundance of the INB, we used CCE to collect HeLa cells in G1 phase. G1 cells were allowed to re-settle and were analysed at different time points after CCE for abundance of the INB in different cell cycle stages. Interestingly, 12 h after CCE with most cells being in S phase (see Supplementary Figure S[3](#Fig9){ref-type="supplementary-material"}e), ∼71% of cells (±10.5%) displayed an INB for PA28γ. When cells progressed into G2 phase (18 h after CCE), this number decreased to ∼55% (±8.8%). In contrast, only ∼19% (±3.6%) of cells in G1 phase (2 h after CCE) contained an INB for PA28γ. The low abundance of the INB during G1 was confirmed by analysis of cells after nocodazole release (data not shown) and is therefore unlikely to be an artefact of the CCE. These data indicate that the INB is prevalent in cells in S and G2 phase of an unperturbed cell cycle. The induced formation of the INB by specific DNA-damaging agents therefore could reflect either cells arrested in S phase and/or cells that have retained the INB after exit from S phase into G2 due to DNA damage.

Recently, an accumulation of p21 in the nucleolus has been reported at sites distinct from the localisation of nucleolar markers seen upon DNA damage by UV or adriamycin (Abella et al. [@CR1]). This was accompanied by a segregation of the fibrillar and granular components and by formation of nucleolar caps as a result of transcriptional inhibition. To analyse whether the INB might be induced by similar mechanisms, we examined the effect of IR irradiation on nucleolar architecture and function. No change was observed in the localisation of UBF and Nop58, as marker for the FC and DFC, respectively, after 3 h of recovery from IR (Fig. [5a](#Fig5){ref-type="fig"}). This was also true either at shorter (5 min to 1 h) and longer recovery periods (up to 12 h) after IR, or in cells that were incubated for 24 h in the presence of either HU or CPT (data not shown). Treatment of cells with low doses of actinomycin D (actD, 5 nM for 3 h), to specifically inhibit RNA pol I activity, however, resulted in formation of nucleolar caps for both UBF and fibrillarin (Fig. [5a](#Fig5){ref-type="fig"}, lower panel). Fig. 5Stress stimuli triggering the intranucleolar body do not interfere with nucleolar function. **a** HeLa cells were either left untreated, exposed to 10 Gy (3 h recovery) or treated for 3 h with 5 nM actinomycin D (actD) and subsequently analysed by immunofluorescence using antibodies against UBF and Nop58. *Bar*, 10 μm. **b** Untreated HeLa cells (−), cells exposed to 10 Gy (IR; 3 h recovery) or after 3 h of treatment with 5 nM actinomycin D (act D) were pulse-labelled with EU for 10 min and subsequently analysed by fluorescence microscopy. *Bar*, 10 μm. **c** Untreated HeLa cells (−) or cells 1 h after exposure to 10 Gy (IR) were pulse-labelled with \[5,6-3H\]uridine (3H) for 2 h, total RNA isolated and analysed by northern blot and subsequent autoradiography. The ethidium bromide stain (EtBr) of the total 18S rRNA is shown as a loading control. **d** Quantification of cells displaying an intranucleolar body for endogenous PA28γ in cells left untreated (−IR), 3 h after exposure to 10 Gy in the absence (+IR) or presence (IR/1 h act D) of 5 nM actinomycin D for 1 h. *Error bars* represent the standard deviation of three (−IR, +IR) or two (IR/actD) independent experiments with \>100 cells each. The *p* value was determined using a heteroscedastic, two-tailed *t* test and is indicated as *single asterisk* for *p* ≤ 0.05 (significant)

The preservation of nucleolar architecture upon IR treatment indicates ongoing transcriptional activity in the nucleolus. To address this directly, we labelled freshly synthesised RNA by pulse labelling with 5-ethynyl uridine (EU) and analysed the amount of EU incorporation by fluorescence microscopy. Due to the high transcription rate of rRNA, nucleoli appear strongly labelled compared with the nucleoplasm (Fig. [5b](#Fig5){ref-type="fig"}, control). We did not detect a change in the level of transcription in IR-treated cells compared with control cells, confirming that irradiated cells were indeed transcriptionally active, as suggested by their normal nucleolar architecture. In contrast, treatment of cells with low doses of actD (5 nM) significantly reduced the level of EU incorporation specifically within the nucleoli without reduction in the rate of nucleoplasmic transcription (Fig. [5b](#Fig5){ref-type="fig"}).

In ribosomal biogenesis, the primary 47/45S rRNA transcript is processed into the final 28S, 18S and 5.8S rRNAs. So, even though cells are actively transcribing rRNA as determined by EU incorporation, the processing of the rRNA precursor might still be affected by IR. Therefore, we examined transcription and processing of rRNA in unstressed and irradiated cells by metabolic labelling with \[5,6-^3^H\]-uridine and subsequent northern blot analysis. In agreement with the level of EU incorporation, no change in the amount of the primary 45/47S rRNA transcript could be observed upon IR (Fig. [5c](#Fig5){ref-type="fig"}). Furthermore, its processing into the 32S rRNA intermediate and final 28S and 18S rRNA products was not prevented by IR.

In conclusion, IR promotes the formation of the INB without disrupting nucleolar structure or function. This is in agreement with our observation that already a fraction of unstressed cells with normal nucleolar morphology appears to have an INB (Fig. [1a](#Fig1){ref-type="fig"}).

To analyse whether the presence of the INB in turn depends on nucleolar transcription activity, we compared untreated cells with irradiated cells that were additionally incubated for 1 h in the absence or presence of low doses of actinomycin D to specifically inhibit RNA pol I. The IR-induced formation of the INB was abolished by the short inhibition of RNA pol I transcription (Fig. [5d](#Fig5){ref-type="fig"}). Longer incubation of either irradiated, or untreated, cells with actinomycin D (up to 3 h) led to loss of the INB (data not shown), suggesting that it is dependent on intact nucleolar structure and/or nucleolar transcription.

The intranucleolar body is in close proximity to ribosomal DNA {#Sec19}
--------------------------------------------------------------

During our analysis, we noticed the presence of a DNA fibre, either in close proximity to, or, in some cases, wrapped around the INB. Nucleoli are known to form around rDNA repeats, but other chromatin regions are also known to associate with the nucleolus in mammalian cells, such as telomeres, centromeres and other recently identified 'nucleolar-associated domains' (NADs; Carvalho et al. [@CR17]; Haaf and Schmid [@CR33]; Manuelidis [@CR60]; Manuelidis and Borden [@CR61]; Nemeth et al. [@CR68]; Ochs and Press [@CR69]; van Koningsbruggen et al. [@CR105]). To determine whether these intranucleolar DNA fibres associated with the INB correspond to rDNA, we combined DNA-FISH for rDNA with immunostaining for SUMO1 to detect the INB and immunolabelling for the known rDNA binding protein UBF in HeLa cells stably expressing His-SUMO1. The rDNA probe labelled nucleoli, demonstrating the specificity of the hybridization. When individual *z*-stacks of cells displaying the intranucleolar SUMO1-body were analysed, the rDNA-probe labelled the DNA fibre directly beside the INB (arrows in Fig. [6a](#Fig6){ref-type="fig"}, top panel). The same result was obtained using antibodies specific for either endogenous PA28γ (Supplementary Figure S[4a](#Fig10){ref-type="supplementary-material"}), or an rDNA probe specific for a different rDNA region (data not shown). Other nucleolar-associated DNA domains (NAD), such as the telomeres on the short arm of chromosome 4 (van Koningsbruggen et al. [@CR105]), did not exhibit close proximity to the INB, demonstrating that we were able to distinguish individual NADs spatially even in a confined space such as the nucleolus (Supplementary Figure S[4a](#Fig10){ref-type="supplementary-material"}). This association was also preserved under conditions that promote formation of the INB, such as IR or CPT treatment (Fig. [6a](#Fig6){ref-type="fig"}, lower panel and data not shown). Transcription of rDNA accounts for the majority of cellular transcription. Having identified a number of factors involved in RNA splicing within the nucleolar body (see Table [1](#Tab1){ref-type="table"}), we wondered whether they were involved in rRNA transcription and/or processing. However, when we labelled nascent RNA by EU incorporation, we could not detect any co-localisation with the INB (as shown for PA28γ in Fig. [6b](#Fig6){ref-type="fig"}), suggesting that the INB may not be a site of either rRNA transcription or processing. Fig. 6The intranucleolar body is associated with transcriptionally silent ribosomal rDNA (rDNA). **a** Untreated HeLa His-SUMO1 cells (*untr*) or cells 6 h after exposure to 10 Gy (IR) were analysed by combined FISH for rDNA and immunofluorescence for SUMO1 and UBF. The DNA and UBF stain were omitted in the *insets*. An *arrow* points towards the INB with associated rDNA. **b** HeLa cells were subjected to 10 min pulse-labelling with EU, and subsequently analysed by indirect immunofluorescence using antibodies for PA28γ. The INB for PA28γ is indicated (*arrow*). **c** HeLa cells were subjected to double immunofluorescence for PA28γ and trimethylated lysine 9 histone H3 (H3K9me3) (top), lysin16 acetylated histone H4 (H4K16ac; *middle panel*) or HP1α (*bottom*), respectively. The DNA stain was omitted in the *insets*. *Arrows* point towards the localisation of the INB. *Bar*, 10 μm

UBF is an rDNA transcription factor that is involved in establishing a euchromatic state of rDNA (reviewed in McStay and Grummt ([@CR63]) and Sanij and Hannan ([@CR83])). No co-localisation of the INB with either UBF or RNA pol I (RPA194), both markers for the FC, could be observed (see Figs. [1a](#Fig1){ref-type="fig"} and [6a](#Fig6){ref-type="fig"}). In fact, the SUMO1-nucleolar body and UBF mostly appeared mutually excluded on rDNA (Fig. [6a](#Fig6){ref-type="fig"}).

Next, we tested whether the INB might be associated with transcriptionally silent, heterochromatic DNA. Eu- and heterochromatic DNA can be distinguished by specific histone modifications, such as lysine 9 trimethylated histone H3 (H3K9me3) or lysine 20 trimethylated histone H4 (H4K20me3) for heterochromatin and lysine 16 acetylated histone H4 (H4K16ac) or lysine 36 trimethylated histone H3 (H3K36me3) for euchromatin (Bannister et al. [@CR10], [@CR11]; Shogren-Knaak and Peterson [@CR89]; Vakoc et al. [@CR104]; Schmitz et al. [@CR86]; Schotta et al. [@CR87]). By immunofluorescence, we found the heterochromatin markers H3K9me3 and H4K20me3 directly adjacent to the INB stained for PA28γ (Fig. [6](#Fig6){ref-type="fig"}c and Supplementary Figure S[4](#Fig10){ref-type="supplementary-material"}b, top panel, indicated by arrows). The euchromatic marker H4K16ac, however, was excluded from this intranucleolar DNA fibre and not found near the INB (Fig. [6c](#Fig6){ref-type="fig"}, middle panel). Proteins involved in gene repression, such as the heterochromatin protein 1 (HP1), are known to be recruited by histone modifications such as H3K9me3 (Bannister et al. [@CR10]; Lachner et al. [@CR44]; Nakayama et al. [@CR67]). As shown in Fig. [6c](#Fig6){ref-type="fig"} (arrows in lower panel), HP1α localises adjacent to the INB. Also, the transcriptional co-repressor TRIM28 can be found together with PA28γ in the INB (Supplementary Figure S[4](#Fig10){ref-type="supplementary-material"}b, lower panel), further supporting the hypothesis that the INB might be associated with transcriptionally silent rDNA.

Discussion {#Sec20}
==========

In this study, we identify 22 factors, encompassing 21 proteins and one RNA component (TMG), in a subnucleolar region that is not directly associated with sites of rRNA synthesis. For a few proteins, this intranucleolar localisation has been observed before, e.g. for SUMO1, CRM1, CDC5L, coilin and splicing snRNPs (Ajuh et al. [@CR3]; Desterro et al. [@CR22]; Ernoult-Lange et al. [@CR24]; Lyon et al. [@CR53]; Sleeman et al. [@CR93]; Sleeman and Lamond [@CR92]); however, the conditions of their intranucleolar localisation and dynamics have not been characterized in detail. Importantly, despite the presence of the Cajal body marker coilin in the INB, the level of coilin within the INB does not correspond to the locally high concentration of coilin seen accumulated in Cajal bodies. Rather, the level of coilin in the INB is similar to the nucleoplasm. Furthermore, many of the factors detected in the INB are not present in Cajal bodies. Therefore, we exclude that the INB corresponds to Cajal bodies within the nucleolus.

Some of the factors localized to the INB are known to either interact directly, or else to be part of the same protein or RNP complex, for example, PA28γ with the 20S proteasome, CDC5L, PLRG1 and Prp19 within the CDC5L complex and TMG-capped snRNAs with snRNPs (Ajuh et al. [@CR2]; Andersen and Zieve [@CR6]; Mao et al. [@CR62]). These constituents of the INB are involved in diverse functions including the cellular stress response to DNA damage, DNA replication, pre-mRNA splicing, protein turnover and chromatin organization. Several of these proteins are implicated in multiple cellular processes. For example, the Ser/Thr phosphatase PPM1G has been shown to influence the subcellular localisation of SMN, to act in pre-mRNA splicing, in dephosphorylation of coilin, histone H2B and γH2AX as well as in histone H2A/H2B exchange (Allemand et al. [@CR5]; Hearst et al. [@CR36]; Kimura et al. [@CR40]; Murray et al. [@CR66]; Petri et al. [@CR77]). The CDC5L complex and its constituents CDC5L, PLRG1 and Prp19 have additionally been linked to the DNA damage response (Legerski [@CR47]; Lu and Legerski [@CR51]; Zhang et al. [@CR110], [@CR111]).

Post-translational protein modifications with SUMO1 and SUMO2/3 are well known to have multiple roles, such as regulating protein activity, stability and/or subcellular localisation, and have also been linked to rDNA maintenance (reviewed in Eckert-Boulet and Lisby ([@CR23]) and Geiss-Friedlander and Melchior ([@CR28])). We recently reported a proteomic screen for SUMOylated proteins within the nucleolus, demonstrating a role for SUMOylation of Nop5/Nop58 in the regulation for snoRNP biogenesis (Westman et al. [@CR106]). However, if snoRNP proteins are the major targets for SUMOylation in the nucleolus, they mainly localise in the DFC and do not co-localise with the INB (data not shown). In the future, it will be interesting to identify the SUMOylated proteins within the INB and to determine their function within the nucleolus.

We were also able to detect SUMO1 by immuno-EM in the INB within purified nucleoli. Here, they associated with nucleolar cavities. As we were not able to observe these cavities by EM of nucleoli in unfractionated intact cells, the INB might either represent an area of reduced structural stability compared to other nucleolar compartments or, alternatively, may be obscured by components that were lost during nucleoli purification.

Recently, an intranucleolar localisation different to FC, DFC or GC was described upon MG132 or adriamycin treatment for p53 and p21, respectively (Abella et al. [@CR1]; Kruger and Scheer [@CR43]; Latonen et al. [@CR46]). However, both these treatments interfere with the integrity and/or function of the nucleolus. MG132 has been described to cause either nucleolar aggregates and/or nucleoplasmic invaginations into the nucleolus (Kruger and Scheer [@CR43]; Latonen et al. [@CR46]), whereas adriamycin treatment, like UV-irradiation, results in inhibition of rRNA synthesis and nucleolar cap formation (Abella et al. [@CR1]). Importantly, the INB we observe is a feature of intact and functional nucleoli. In contrast to p21 or p53, the components of the INB detected in this study are continuously expressed and are located within the INB of unstressed cells, albeit with a lower frequency. Also, neither nucleolar structure nor ribosome subunit biogenesis are prevented by stress treatments that promote formation of the INB. Of course, we cannot exclude an influence of the DNA-damaging agents on the nucleolus, which cause little change to its architecture and functionality but that might indirectly trigger the formation of the INB.

We were able to show that formation of the INB is dependent on a functional nucleolus because inhibition of RNA pol I transcription by short-term treatment with low doses of actinomycin D abolished INB formation upon DNA damage. A basal transcriptional activity has been suggested to occur in nucleoli of hibernating dormice, which have been shown to contain coilin located in an INB (Malatesta et al. [@CR59]). These results are consistent with the data obtained in lens tissue, as the epithelial cell layer that contains an INB has been shown to be transcriptionally active at a low level, whereas differentiated fibre cells, which do not exhibit an INB, are either transcriptionally highly active (early differentiated fibre cells) or transcriptionally silent (late fibre cells). Therefore, the INB we describe here may be different to the intranucleolar localisation described for p53 and p21. Our data however agree with the recent report of the presence of subnucleolar bodies containing CRM1, whose presence is dependent on ongoing RNA pol I activity (Ernoult-Lange et al. [@CR24]). However, in contrast to CRM1, localisation of other components to the INB could not be inhibited by the drug leptomycin B (LMB), suggesting their recruitment occurs independently of CRM1 (Ernoult-Lange et al. [@CR24]; own observation).

Interestingly, different components within the INB appeared to have distinct turnover rates when analysed by FRAP. In contrast to the highly mobile INB components PA28γ and PPM1G (recovery within ∼1 min), SUMO-conjugated proteins exhibited a very low (though measurable) mobility. This result indicates that the INB likely does not represent protein aggregates, such as those described for nuclear proteins within the nucleolus upon proteasome inhibition (Latonen et al. [@CR46]).

The observation that the INB is mostly abundant in cells during S phase, localises in close proximity to rDNA and is promoted by specific DNA damaging agents might indicate that, at least in part, its components are linked to the maintenance of rDNA repeats. As shown in Table [1](#Tab1){ref-type="table"}, we identified several proteins within the INB that are implicated in DNA repair, such as DNA-PK, Ku70, PCNA and components of the CDC5L complex. Interestingly, replication of rDNA repeats in *Saccharomyces cerevisiae* has been shown to involve stalled replication forks as part of the regular replication mechanism, and this has been suggested to lead to increased recombinational activity within the rDNA locus (Brewer and Fangman [@CR16]; Kobayashi et al. [@CR41]; Linskens and Huberman [@CR48]). Also, it has been recently reported that maintaining integrity of rDNA is very important because deletion of rDNA repeats affects nucleolar structure, alters the balance between genomic eu- and heterochromatin in *Drosophila*, and changes life-span in yeast by mechanisms involving DNA recombination and repair (Paredes and Maggert [@CR72]; Prokopowich et al. [@CR79]). Therefore, the periodic appearance and disappearance of the INB (Fig. [3d](#Fig3){ref-type="fig"}) might indicate a basal level of DNA repair for rDNA gene arrays in unstressed cells during the cell cycle. The presence of several markers for heterochromatic and transcriptionally silent DNA, such as H3K9me3, H4K20me3 and HP1α on the rDNA associated with the INB and the transcriptional co-repressor TRIM28 within the INB, could potentially indicate the rDNA repeats are transcriptionally repressed. However, histone modifications such as H3K9me3 have also been described to occur in active genes, preventing a precise conclusion about the transcriptional activity of these rDNA repeats. Moreover, it is well possible that the INB might serve more than one function. Many proteins found within the INB are not known to be involved in the DNA damage response or chromatin organisation, such as SF2 or CRM1. We also observed a drastic reduction of the INB by staining for PA28γ upon reduced snRNP assembly, caused by RNAi-mediated depletion of SMN (data not shown). These issues therefore require further investigation.

Additionally to its association with rDNA, the presence of the INB can be abolished by treatment of cells with actD. It is therefore possible that DNA damage is dependent upon active transcription of rDNA genes. As inhibition of RNA pol I activity also interferes with nucleolar structure; we are not able to distinguish whether the INB is primarily dependent on ongoing transcription and/or nucleolar integrity. It would also be interesting to test whether the formation of the INB is dependent on existing heterochromatin, or even is involved in its formation.
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###### 

The INB in tissue from human skin. Sections from human skin (shoulder) were processed and stained with specific antibodies for SUMO1 (*green*) and fibrillarin (*red*) and subsequently analysed by confocal microscopy. A DIC and fluorescently labelled section of the tissue is shown in (*I*) with the epithelial layer shown in high magnification in (*II*) indicated by a *box*. *Bar*, 20 μm. (*II*) The nucleolus shown in the magnification in all three midplanes in the *panel below* is indicated by an *arrow*. Further nucleoli containing an INB are indicated by *arrowheads*. *Bar*, 5 μm. For clarity, only the stain for SUMO1 (*green*) and fibrillarin (*red*) is shown in the magnifications (JPEG 102 kb)

###### 

High resolution image (TIFF 7259 kb)

###### 

The INB is induced by specific types of DNA damage. **a** HeLa His-SUMO1 cells were control treated (DMSO) or treated with 25 nM camptothecin (CPT) for 24 h and analysed with antibodies for SUMO1 and nucleolin. The INB is indicated by an *arrow*. **b** Quantification of HeLa His-SUMO1 cells displaying an intranucleolar body for SUMO1 after various stress treatments. *Error bars* represent the standard deviation of *n* = 2 (IR (6 h recovery), UV), *n* = 3 (CPT), *n* = 4 (HU, eto) and *n* = 5 (NQO) independent experiments with \>100 cells evaluated each. *p* values were determined using a heteroscedastic, two-tailed *t* test and are indicated as *single asterisk* for *p* ≤ 0.05 (significant), *double asterisk* for *p* ≤ 0.01 (highly significant) and *triple asterisk* for *p* ≤ 0.001 (very highly significant). **c** As control for the functionality of NQO as UV-mimetic agent, HeLa cells were either treated with DMSO (−NQO) or 1 μM NQO (+NQO) for 3 h and subsequently analysed by immunostaining using specific antibodies for UBF and Nop58 for the presence of nucleolar caps. *Bar*, 10 μm. **d** Whole cell lysate of HeLa cells treated for 3 h with either DMSO (−eto) or 50 μM etoposide (+eto) was analysed by western blot for the presence of H2AX phosphorylation (γH2AX) as control for induction of DSBs. The antibody against α-tubulin serves as a loading control (JPEG 86 kb)
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High resolution image (TIFF 1591 kb)

###### 

The frequency of the INB during the cell cycle. Representative cell cycle profile of HeLa cells 3 h after exposure to 10 Gy IR (**a**), treated for 3 h with 50 μM eto (**b**), for 24 h with 25 nM CPT (**c**) or for 24 h with 2 mM HU (**d**) were stained with propidium iodide and their DNA content subsequently analysed by flow cytometry. **e** Cell cycle profile of HeLa cells that were enriched in G1 phase by CCE and harvested after 2, 12 and 18 h in comparison to an asynchronous cell population. The percentages of cells of the respective samples in G1, S and G2 phase are indicated in the table. These data are representative for one out of three experiments used to analyse the INB frequency during the cell cycle of cells in the absence of DNA damage (JPEG 175 kb)
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High resolution image (TIFF 1214 kb)

###### 

Analysis of nucleolar DNA associated with the INB. **a** HeLa cells were analysed by combined FISH for rDNA (*blue*) and the 4p telomere (*green*; *arrowhead*) and immunofluorescence for PA28γ (*red*, INB indicated by *arrow*). Counterstained DNA is shown in *grey*. *Bar*, 10 μm. **b** HeLa cells were double labelled with specific antibodies for PA28γ and either trimethylated H4K20 (H4K20me3, *upper panel*) or the transcriptional co-repressor TRIM28 (*lower panel*). *Bar*, 10 μm (JPEG 99 kb)
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High resolution image (TIFF 2351 kb)
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